 |
Galectin-3 is a biomarker of inflammation, fibrosis, cardiovascular research, metabolic syndrome and tumors. SK00199-01 had been used by following:
Citation:
- Zeinab H. El-Sayed, et al. "New Biomarkers of Chronic Heart Failure in Relation to Metabolic Syndrome and its Components" AAMJ, Vol.9, N. 3, September, 2011, Suppl.-1
- Pelin Ergun et al. "Possible diagnostic markers for Mucopolysaccharidoses; Cathepsin-D, Galectin-3 and Chitotriosidase" Behcet Uz Cocuk Hast Derg. 2017; 7(2): 95-100 | DOI: 10.5222/buchd.2017.095
- Hamdi Pusuroglu et al. "Galectin-3 is associated with coronary plaque burden and obstructive sleep apnoea syndrome severity" Kardiol Pol. 2017;75(4):351-359. doi: 10.5603/KP.a2016.0185
- Gaofeng Song, et al. Increased serum galectin-3 levels are associated with the development of type 2 diabetic nephropathy: a novel marker for progression? Int J Clin Exp Med 2018;11(7):7156-7164
New Galectin Research
- Ramos-MartÃnez E, et al. Association between Galectin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis. Biomolecules. 2022 Jul 31;12(8):1062.
|
|
|